CA2949754A1 - Use of aminoglycoside analogs in the treatment of rett syndrome - Google Patents
Use of aminoglycoside analogs in the treatment of rett syndrome Download PDFInfo
- Publication number
- CA2949754A1 CA2949754A1 CA2949754A CA2949754A CA2949754A1 CA 2949754 A1 CA2949754 A1 CA 2949754A1 CA 2949754 A CA2949754 A CA 2949754A CA 2949754 A CA2949754 A CA 2949754A CA 2949754 A1 CA2949754 A1 CA 2949754A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- alkyl
- mecp2
- rett syndrome
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462008028P | 2014-06-05 | 2014-06-05 | |
| US62/008,028 | 2014-06-05 | ||
| PCT/IL2015/050573 WO2015186134A1 (en) | 2014-06-05 | 2015-06-04 | Use of aminoglycoside analogs in the treatment of rett syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2949754A1 true CA2949754A1 (en) | 2015-12-10 |
Family
ID=53525222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2949754A Abandoned CA2949754A1 (en) | 2014-06-05 | 2015-06-04 | Use of aminoglycoside analogs in the treatment of rett syndrome |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20170360817A1 (https=) |
| EP (1) | EP3151840A1 (https=) |
| JP (1) | JP2017516835A (https=) |
| CA (1) | CA2949754A1 (https=) |
| IL (1) | IL249402A0 (https=) |
| WO (1) | WO2015186134A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20180056T1 (hr) | 2010-11-18 | 2018-02-09 | Technion Research & Development Foundation Ltd. | Aminoglikozidi i upotreba istih u svrhu liječenja genetskih poremećaja |
| CA2949754A1 (en) | 2014-06-05 | 2015-12-10 | Eloxx Pharmaceuticals Ltd. | Use of aminoglycoside analogs in the treatment of rett syndrome |
| EP3344641A4 (en) * | 2015-09-02 | 2019-09-18 | Eloxx Pharmaceuticals Ltd. | AMINO-LIKES DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF GENETIC DISEASES |
| EP3350194A4 (en) | 2015-09-02 | 2019-04-24 | Eloxx Pharmaceuticals Ltd. | AMINO-LIKES DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF GENETIC DISEASES |
| EP3344640A4 (en) | 2015-09-02 | 2019-05-01 | Eloxx Pharmaceuticals Ltd. | AMINO-LIKES DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF GENETIC DISEASES |
| AU2018235441C1 (en) * | 2017-03-15 | 2024-10-24 | Eloxx Pharmaceuticals Ltd. | Large scale preparation of pseudo-trisaccharide aminoglycosides and of intermediates thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5960712A (ja) | 1982-09-30 | 1984-04-06 | Toshiba Corp | デ−タ判別装置 |
| CA2554380C (en) * | 2004-02-17 | 2015-05-19 | The Hospital For Sick Children | Mecp2e1 gene |
| EP2390255B1 (en) * | 2006-04-03 | 2016-07-13 | Technion Research & Development Foundation Ltd. | Novel aminoglycosides and uses thereof in the treatment of genetic disorders |
| HRP20180056T1 (hr) | 2010-11-18 | 2018-02-09 | Technion Research & Development Foundation Ltd. | Aminoglikozidi i upotreba istih u svrhu liječenja genetskih poremećaja |
| CA2949754A1 (en) | 2014-06-05 | 2015-12-10 | Eloxx Pharmaceuticals Ltd. | Use of aminoglycoside analogs in the treatment of rett syndrome |
-
2015
- 2015-06-04 CA CA2949754A patent/CA2949754A1/en not_active Abandoned
- 2015-06-04 JP JP2016571284A patent/JP2017516835A/ja active Pending
- 2015-06-04 EP EP15735743.5A patent/EP3151840A1/en not_active Withdrawn
- 2015-06-04 WO PCT/IL2015/050573 patent/WO2015186134A1/en not_active Ceased
- 2015-06-04 US US15/316,209 patent/US20170360817A1/en not_active Abandoned
-
2016
- 2016-12-05 IL IL249402A patent/IL249402A0/en unknown
-
2019
- 2019-01-28 US US16/258,735 patent/US10576095B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20190183915A1 (en) | 2019-06-20 |
| WO2015186134A1 (en) | 2015-12-10 |
| JP2017516835A (ja) | 2017-06-22 |
| US10576095B2 (en) | 2020-03-03 |
| EP3151840A1 (en) | 2017-04-12 |
| IL249402A0 (en) | 2017-02-28 |
| US20170360817A1 (en) | 2017-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10576095B2 (en) | Use of aminoglycoside analogs in the treatment of Rett syndrome | |
| RU2677276C2 (ru) | Способы лечения рака | |
| Dileep et al. | Synthesis of novel tetrazole containing hybrid ciprofloxacin and pipemidic acid analogues and preliminary biological evaluation of their antibacterial and antiproliferative activity | |
| US12285470B2 (en) | Trim proteins and galectins cooperate and codirect autophagy and are useful in the treatment of autophagy related diseases | |
| US20180338973A1 (en) | Pyrimidine derivative and use thereof | |
| WO2022095972A1 (zh) | 异喹啉类化合物在治疗肿瘤中的应用 | |
| US10722515B2 (en) | Dual CLK/CDK1 inhibitors for cancer treatment | |
| US20210220380A1 (en) | Aminoglycoside derivatives and uses thereof in treating genetic disorders | |
| CN114796254A (zh) | 多杀菌素衍生物作为精氨酸代琥珀酸合成酶激活剂及其应用 | |
| JP2018138609A (ja) | ナフチリジンジオン誘導体 | |
| US20220281803A1 (en) | Molecular design of new antibiotics and antibiotic adjuvants against mcr strains | |
| US10934326B2 (en) | Peripheral modifications on pocket-redesigned vancomycin analogs synergistically improve antimicrobial potency and durability | |
| US20230312597A1 (en) | Novel compounds with antibacterial and anti viral activities | |
| US20110263574A1 (en) | Pirenzepine as otoprotective agent | |
| US20190127313A1 (en) | Antimicrobial agents | |
| US20230151021A1 (en) | Compounds and Compositions for Treating Hematologic Malignancies | |
| Buchkevych et al. | Synthesis of New 6, 7 (N, O)-Heterocyclic 1, 4-Naphthoquinones | |
| AU2016333908A1 (en) | Potentiator-corrector combinations useful in the treatment of cystic fibrosis | |
| EP2864332A1 (en) | Imidazo bicyclic imminium compounds as antitumor agents | |
| US20210393677A1 (en) | Compounds for modulation and as functional replacement of alphaketoglutaric acid (2og)-dependent oxygenases | |
| Malhotra et al. | Benzylidene/2-aminobenzylidene hydrazides: Synthesis, characterization and in vitro antimicrobial evaluation | |
| WO2025248025A1 (en) | Inhibitors of the elongator complex | |
| KR100780868B1 (ko) | 항암효과를 나타내는 4급 아미노 글루코사민 화합물 | |
| US20180147200A1 (en) | Method of inducing autophagy | |
| US20200392126A1 (en) | Isoxazolyl compounds as receptor modulating compounds and methods and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20211123 |